Abstract
Our goal was to evaluate the clinical patterns, additional risk factors, treatment and outcome of cerebral venous thrombosis (CVT) related to adolescent oral contraceptive pill (OCP) usage. We evaluated 22 patients with CVT related to OCPs admitted to Firat and Dicle University Hospitals from January 2008 to January 2013. We assessed the clinical features, risk factors, imaging results and prognosis. Magnetic resonance imaging (MRI) and magnetic resonance were the preferred procedures for the diagnosis of CVT. MRI revealed parenchymal lesions in 11 (50 %) patients, and the remaining patients had normal MRIs. The sinuses most frequently affected by thrombosis were the superior sagittal sinus and the transverse sinus. The additional risk factors identified for CVT were antiphospholipid syndrome, protein C deficiency, protein C and S deficiency, factor V Leiden associated with heterozygous antithrombin III deficiency, methylenetetrahydrofolate reductase and prothrombin gene mutations. CVT may be overlooked in adolescents because it is more common among middle-aged and elderly adults. CVT should be suspected in the presence of neurological symptoms in adolescents, especially in those using OCPs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Santos GR, André R, Pereira SL, Parreira T, Machado E (2011) Cerebral venous thrombosis: retrospective analysis of 49 cases. Acta Med Port 24(1):21–28
Crassard I, Bousser MG (2006) Cerebral venous thrombosis. Rev Med Intern 27:117–124
Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338:1793–1797
Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF (2006) Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 26:19–41
Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM (2010) Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation 121:2740–2746
Otrock ZK, Taher AT, Shamseddeen WA, Mahfouz RA (2008) Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosis. J Thromb Thrombolysis 26:41–43
Parker M, Sneddon A, Arbon P (2010) The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG 117(2):185–192
Andersch B, Milsom I (1982) An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 144(6):655–660
Hillen TI, Grbavac SL, Johnston PJ, Straton JA, Keogh JM (1999) Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 25(1):40–45
Jones RK (2011) Beyond birth control: the overlooked benefits of oral contraceptive pills. Guttmacher Institute, New York
World Health Organization (1992) International statistical classification of diseases and related health problems 10th revision, vol 1. World Health Organization, Geneva
Stam J (2005) Thrombosis of the cerebral veins and sinuses. N Engl J Med 352:1791–1798
Kajtazi NI, Zimmerman VA, Arulneyam JC, Al-Shami SY, Al-Senani FM (2009) Cerebral venous thrombosis in Saudi Arabia. Clinical variables, response to treatment, and outcome. Neurosciences (Riyadh) 14:349–354
Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670
Algahtani HA, Abdu AP, Shami AM, Hassan AE, Madkour MA, Al-Ghamdi SM, Malhotra RM, Al-Khathami AM (2011) Cerebral venous sinus thrombosis in Saudi Arabia. Neurosciences (Riyadh) 16(4):329–334
Lafitte F, Boukobza M, Guichard JP, Hoeffel C, Reizine D, Ille O, Woimant F, Merland JJ (1997) MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis (CVT). Clin Radiol 52(9):672–679
Cumurciuc R, Crassard I, Sarov M et al (2005) Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry 76:1084
Zafar A, Ali Z (2012) Pattern of magnetic resonance imaging and magnetic resonance venography changes in cerebral venous sinus thrombosis. J Ayub Med Coll Abbottabad 24(1):63–67
Eichinger S, Evers JL, Glasier A, La Vecchia C, Martinelli I et al (2013) Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 19(5):471–482
Bousser MG, Crassard I (2012) Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res 130(Suppl 1):19–22
Radaković B, Goldstajn MS (2007) MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome. Coll Antropol 31(3):919–921
Shulman LP, Goldzieher JW (2003) The truth about oral contraceptives and venous thromboembolism. J Reprod Med 48(11 Suppl):930–938
Okoroh E, Hooper WC, Atrash HK et al (2012) Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003–2008. Am J Obstet Gynecol 207:377
Demir CF, Inci MF, Özkan F, Yıldız M, Özdemir H (2013) Clinical and radiological management and outcome of pregnancies complicated by cerebral venous thrombosis: a review of 19 cases. J Stroke Cerebrovasc Dis 22(8):1252–1257
Peake LJ, Grover SR, Monagle PT, Kennedy AD (2011) Effect of warfarin on menstruation and menstrual management of the adolescent on warfarin. J Paediatr Child Health 47(12):893–897
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özdemir, H.H., Varol, S., Akıl, E. et al. Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents. Neurol Sci 36, 149–153 (2015). https://doi.org/10.1007/s10072-014-1914-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-014-1914-2